These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4147573)
1. Parkinson's disease. A genetic study. Martin WE; Young WI; Anderson VE Brain; 1973 Sep; 96(3):495-506. PubMed ID: 4147573 [No Abstract] [Full Text] [Related]
2. Editorial: Status of tyrosine hydroxylase in the healthy and Parkinson's brain. Kamal MA CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):336-9. PubMed ID: 22583447 [No Abstract] [Full Text] [Related]
3. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. McGeer PL; McGeer EG J Neurochem; 1976 Jan; 26(1):65-76. PubMed ID: 3629 [No Abstract] [Full Text] [Related]
8. The etiology of Parkinson's disease. Strang RR Dis Nerv Syst; 1970 Jun; 31(6):381-90. PubMed ID: 5456765 [No Abstract] [Full Text] [Related]
9. Analysis of a founder mutation in the TH gene in a cohort of greek patients with Parkinson's disease. Pons R; Kekou K; Antonellou R; Svingou M; Kanavakis E; Stefanis L Mov Disord; 2016 Nov; 31(11):1753-1754. PubMed ID: 27666733 [No Abstract] [Full Text] [Related]
10. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects. Nagatsu T; Nagatsu I J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309 [TBL] [Abstract][Full Text] [Related]
11. CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies. Riederer P; Rausch WD; Birkmayer W; Jellinger K; Seemann D J Neural Transm Suppl; 1978; (14):121-31. PubMed ID: 39974 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Parkinson's disease in a population of Uruguay. Preliminary results. Chouza C; Ketzoian C; Caamaño JL; Cáceres R; Coirolo G; Dieguez E; Rega I Adv Neurol; 1996; 69():13-7. PubMed ID: 8615121 [No Abstract] [Full Text] [Related]
13. The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies. Golbe LI; Di Iorio G; Lazzarini A; Vieregge P; Gershanik OS; Bonavita V; Duvoisin RC Adv Neurol; 1999; 80():165-70. PubMed ID: 10410717 [No Abstract] [Full Text] [Related]
14. [Hereditary aspects of Parkinson's disease (review of the literature)]. Atadzhanov M Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(6):919-26. PubMed ID: 4584983 [No Abstract] [Full Text] [Related]
15. Genetics of Parkinson's disease: biochemical epidemiologic and neuropathologic correlations. Ambani LM Indian J Med Sci; 1977 Feb; 31(2):21-9. PubMed ID: 614237 [No Abstract] [Full Text] [Related]
16. Molecular biology of catecholamine neurons in relation to Parkinson's disease. Nagatsu T; Ichinose H Adv Neurol; 1996; 69():147-52. PubMed ID: 8615123 [No Abstract] [Full Text] [Related]
17. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease. Gai WP; Vickers JC; Blumbergs PC; Blessing WW J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1039-46. PubMed ID: 7916375 [TBL] [Abstract][Full Text] [Related]
18. Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects. Yokochi M; Narabayashi H; Iizuka R; Nagatsu T Adv Neurol; 1984; 40():407-13. PubMed ID: 6141711 [No Abstract] [Full Text] [Related]
19. A commentary on Axon guidance pathway genes and Parkinson's disease. Tomiyama H J Hum Genet; 2011 Feb; 56(2):102-3. PubMed ID: 21124334 [No Abstract] [Full Text] [Related]
20. Genetic studies in Parkinson's disease. Barbeau A; Roy M; Boyer L Adv Neurol; 1984; 40():333-9. PubMed ID: 6695609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]